Anbio Biotechnology (NNNN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

May15

Anbior Biotech to Attend Three Major International Exhibitions

05:07

Apr29

Anbio Biotechnology released FY2024 Q4 earnings on April 28 (EST), actual revenue USD 1.168 M, actual EPS USD -0.0144

03:00

Anbio Biotechnology released FY2024 9 Months Earnings on April 28, 2025 EST, with actual revenue of USD 7.017 M and EPS of USD 0.0705

03:00

Anbio Biotechnology released FY2024 Annual Earnings on April 28 (EST), with actual revenue of USD 8.185 M and EPS of USD 0.0561

03:00

Anbio Biotechnology released FY2024 Q3 earnings on April 28 (EST), actual revenue USD 1.168 M, actual EPS USD -0.0144

03:00

Jan11

Anbio Biotechnology released FY2022 annual earnings on January 10, 2025 (EST), with actual revenue of 23.54 M USD and EPS of 0 USD

04:00

Schedules & Filings

Schedules

Filings

Apr28

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 1.168 M, Net Income -611.9 K, EPS -0.0144

Feb19

IPO(EST)

Listing Price USD 5

Jan10

Earning Release(EST)

FY2023 Q4 Earning Release (USD) Revenue 1.826 M, Net Income 366.54 K, EPS 0.0086

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change